Results 251 to 260 of about 478,958 (264)

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Lancet, The, 2013
Patrick Marcellin, Edward Gane, Maria Buti   +2 more
exaly  

Chronic hepatitis B virus infection

Lancet, The, 2018
Seto Wk, Jean Michel Pawlotsky, Man-Fung Yuen   +2 more
exaly  

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

Lancet, The, 2015
David Roth, Annette Bruchfeld, AnnMarie Liapakis   +2 more
exaly  

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Lancet, The, 1997
Pierre Bedossa, T Poynard
exaly  

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Lancet, The, 1998
Anders Sönnerborg
exaly  

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Lancet, The, 2019
Fabrice Carrat, Hélène Fontaine, Christophe Hézode   +2 more
exaly  

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
exaly  

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C

Lancet, The, 1993
exaly  

Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Ribavirin treatment for chronic hepatitis C

Lancet, The, 1991
exaly